BOSTON SCIENTIFIC CORPORATION Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- BOSTON SCIENTIFIC CORPORATION payments for repurchase of common stock for the quarter ending 2015-12-31 was $0.00.
- BOSTON SCIENTIFIC CORPORATION payments for repurchase of common stock for the quarter ending 2015-09-30 was $0.00.
- BOSTON SCIENTIFIC CORPORATION payments for repurchase of common stock for the quarter ending 2015-06-30 was $0.00.
- BOSTON SCIENTIFIC CORPORATION payments for repurchase of common stock for the quarter ending 2015-03-31 was $0.00, a 100.00% decline year-over-year.
- BOSTON SCIENTIFIC CORPORATION payments for repurchase of common stock for fiscal 2022 was $0.00.
- BOSTON SCIENTIFIC CORPORATION payments for repurchase of common stock for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- BOSTON SCIENTIFIC CORPORATION payments for repurchase of common stock for fiscal 2020 was $535.00M.
- BOSTON SCIENTIFIC CORPORATION payments for repurchase of common stock for fiscal 2019 was $0.00.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-02-23 | |
| 2021-12-31 | $0.00 10-K · filed 2023-02-23 | |
| 2020-12-31 | $535.00M 10-K · filed 2023-02-23 | |
| 2019-12-31 | $0.00 10-K · filed 2022-02-23 | |
| 2018-12-31 | $0.00 10-K · filed 2021-02-23 | |
| 2016-12-31 | $0.00 10-K · filed 2017-02-23 | |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $0.00 10-K · filed 2017-02-23 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $0.00 derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $0.00 derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-06 | $0.00 derived: sum of 4 quarters · filed 2017-02-23 |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $125.00M 10-K · filed 2017-02-23 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $350.00M derived: sum of 4 quarters · filed 2016-02-24 |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $425.00M derived: sum of 4 quarters · filed 2016-02-24 |
| 2014-03-31 | $125.00M 10-Q · filed 2015-05-06 | $525.00M derived: sum of 4 quarters · filed 2016-02-24 |
| 2013-12-31 | $225.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $500.00M 10-K · filed 2016-02-24 |
| 2013-09-30 | $75.00M 10-Q · filed 2014-11-05 | $375.00M derived: sum of 4 quarters · filed 2015-02-25 |
| 2013-06-30 | $100.00M 10-Q · filed 2014-08-06 | $550.00M derived: sum of 4 quarters · filed 2015-02-25 |
| 2013-03-31 | $100.00M 10-Q · filed 2014-05-08 | $562.00M derived: sum of 4 quarters · filed 2015-02-25 |
| 2012-12-31 | $100.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $600.00M 10-K · filed 2015-02-25 |
| 2012-09-30 | $250.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | $800.00M derived: sum of 4 quarters · filed 2014-02-26 |
| 2012-06-30 | $112.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | $742.00M derived: sum of 4 quarters · filed 2014-02-26 |
| 2012-03-31 | $138.00M 10-Q · filed 2013-05-07 | |
| 2011-12-31 | $300.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-26 | $492.00M 10-K · filed 2014-02-26 |
| 2011-09-30 | $192.00M 10-Q · filed 2011-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |